Form D · Biotechnology

Solenic Medical, Inc.

College Station, TX · CIK 0001785410

Offering snapshot reported Mar 15, 2024 · SEC filing

Reported sold
$3.2M
Offering amount: $4M
Investors reported
17
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Feb 29, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2024Initial$3,200,000No comparison17SEC filing
Feb 2, 2024Initial$2,195,000No comparison9SEC filing
Dec 28, 2022Initial$3,657,498No comparison11SEC filing
Aug 11, 2022Initial$75,000No comparison3SEC filing
May 25, 2021Initial$100,000No comparisonNot reportedSEC filing
May 20, 2020Initial$125,000No comparison3SEC filing
Aug 14, 2019Initial$250,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b, 4a5
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-507801

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Mar 15, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rajiv Chopra Director, Executive
Calvin Goforth Director
R. Calvin Goforth Director
Robert Calvin Goforth Director
David Greenberg Executive
John Hodock Director
James Lancaster Director, Executive
Tamir Meiri Director
John Tepper Director
Mark Wagstaff Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
501 Graham Road
College Station, TX, 77845